Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel H Bonami

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Biorxiv : the Preprint Server for Biology|November 18, 2024
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magady Khalil, et al.
Hypertension (Dallas, Tex. : 1979)|May 25, 2016
Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive HumansHana A Itani, William G McMaster, Mohamed A Saleh, et al.
Cell Reports. Medicine|January 17, 2026
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, et al.
Biorxiv : the Preprint Server for Biology|August 3, 2021
Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA VaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Nature Communications|June 17, 2022
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Plos Pathogens|September 18, 2024
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral familiesMatthew J Vukovich, Andrea R Shiakolas, Jared Lindenberger, et al.
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Biorxiv : the Preprint Server for Biology|November 18, 2024
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magady Khalil, et al.
Hypertension (Dallas, Tex. : 1979)|May 25, 2016
Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive HumansHana A Itani, William G McMaster, Mohamed A Saleh, et al.
Cell Reports. Medicine|January 17, 2026
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, et al.
Biorxiv : the Preprint Server for Biology|August 3, 2021
Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA VaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Nature Communications|June 17, 2022
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Plos Pathogens|September 18, 2024
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral familiesMatthew J Vukovich, Andrea R Shiakolas, Jared Lindenberger, et al.
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Pageof 4